prevalence of 1-2% in Canada. Our hypothesis is PAE overwhelms the aldehyde metabolic enzymes that would normally convert retinol (Vitamin A) to retinoic acid (RA) and reduced RA levels during critical developmental times in early gastrulation underlie the later malformations associated with FAS.
Methods: To biochemically mimic the alcohol-induced RA deficiency in vivo, we genetically engineered a mouse expressing Cyp26A1-eGFP from the endogenous Gsc promoter. The Gsc promoter dictates spatial-temporal expression to the Spemann Mangold Organizer at the start of gastrulation. Cyp26A1 degrades endogenous RA in these cells, mimicking the reduced RA levels induced by acute alcohol exposure and dysregulating the induction of neural crest cells.
Results: Gsc:Cyp26A1 mice were derived by germline transmission; F1 mice are born with a Mendelian ratio of 0.75:1 (het:wt, n= 208). This loss of mutant embryo viability may reflect the prevalent miscarriages observed in human pregnancies with PAE. Gsc: Cyp26A1xRARE-LacZ E8.5 embryos show reduction in RA activity in the frontonasal prominence region (LacZ expression in early face and forebrain). Mutant embryos also demonstrate body-axis developmental variation, indicating early developmental perturbation of RA pathways in FASD relevant tissues (n =48). E18.5 embryos were next examined using scanning EM to demonstrate mutant embryos have sentinel FASD craniofacial malformations: larger philtrum-tophiltrum-lip length ratio, smaller bigonial line width, and smaller whisker pad area (n =66). Gsc:Cyp26A1 mice also develop craniofacial malocclusions at significantly higher rates than WT littermates (12.5% vs 0.04%; n= 208 and 3711, respectively).
Conclusion: Our data provide in vivo evidence that strongly supports RA-deficiency as a major molecular etiology of craniofacial malformations associated with FASD. The finding suggests Vitamin A supplementation may significantly reduce or prevent FASD outcomes in children with PAE. Embryogenesis is a precisely regulated process that requires tight coordination of events in space and, as importantly, in time, yet currently it is unknown how embryos ensure temporally robust development. Embryos are exposed to both endogenous and exogenous cues; yet they reliably develop to their final shape within a predictable timeframe. The process of embryogenesis is therefore able to account and to correct for environmental and intra-embryo noise. Here, we develop procedures to analyze temporal robustness at the whole organism level. Using Drosophila embryos maintained at precise temperatures, we simultaneously image up to 60 embryos from early embryogenesis until larvae hatching. We time the stage of embryogenesis by identifying developmental landmarks. We found that there exists an optimal developmental temperature (21°C) at which the temporal variation between embryos is minimal.
In accordance with previous studies, embryos develop faster at higher temperatures. Whilst this observation can be partially explained by the faster kinetics of various processes at increasing temperature, we next investigated whether active temporal regulators are present, which may, for example, coordinate tissue growth with developmental time. Coupling our setup with microarray analysis and qPCR, we have identified 22 miRNAs that are differentially regulated at varying temperature during embryogenesis. These miRNAs have a broad spectrum of action but, despite being expressed during embryogenesis, their absence does not prevent hatching. Hence, they may have a subtler role, possibly ensuring coordination between developmental processes. We are currently using miRNA knockout and miRNA overexpression to further understand their role in controlling developmental time. Our work represents the first quantitative analysis of temporal variation in embryogenesis and the setup we have developed enables us to explore how time is effectively regulated during embryogenesis. The Ferritin heavy polypeptide-like 17 (Fthl17) gene is a member of the cancer/testis antigen (CTA) genes, which are expressed only in cancer cells and in germ cells. Although previous studies suggested correlation between DNA methylation and the expression of CTA genes including human FTHL17 gene expression, detailed epigenetic regulation of its expression both in cancer cells and in germ cells has not been investigated. To find out regulatory mechanism of Fthl17 gene expression, we assessed the epigenetic regulation of murine Fthl17 gene expression in lung cancer cells and in germline stem cells (GSCs). Fthl17 was more highly expressed in testis, a murine lung cancer cell line, KLN205, and in GSCs than in normal lung tissues. Furthermore, the Fthl17 expression level in GSCs was significantly higher than in KLN205 cells. By bisulfite-sequencing and luciferase reporter assay, we indicated that the 5'-upstream region of Fthl17 was hypo-methylated in KLN205 cells and in GSCs, and hypo-methylation of the -0.6 kb to 0 kb region upstream from the transcription start site (TSS) was involved in its up-regulation in those cells. Because the -0.6 kb to -0.3 kb and the -0.3 kb to 0 kb region were relatively more hypo-methylated in KLN205 cells and in GSCs, respectively, it was suspected that hypo-methylation of the -0.3 kb to 0 kb region caused remarkable increase of Fthl17 expression. Consisting with this idea, treatment with 5-Azacytidine induced hypo-methylation of the -0.3 kb to 0 kb region and upregulation of its expression in KLN205 cells to a level comparable to that in GSCs. Together, our results suggest that hypo-methylation of different but adjacent regions immediately upstream of the Fthl17 gene contribute to differential expression levels in lung cancer cells and in GSCs, and hypo-methylation of the TSS-proximal region is critical for its high-level expression. 
